These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24763826)
1. Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis. Zhong X; Guan X; Dong Q; Yang S; Liu W; Zhang L Tumour Biol; 2014 Jul; 35(7):7155-62. PubMed ID: 24763826 [TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of NEK2 and its clinical significance in non-small cell lung cancer. Zhong X; Guan X; Liu W; Zhang L Oncol Lett; 2014 Oct; 8(4):1470-1476. PubMed ID: 25202351 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ; Jiang YY; Hao JJ; Lu SS; Zhang TT; Shang L; Cao J; Song X; Wang BS; Cai Y; Zhan QM; Wang MR Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [TBL] [Abstract][Full Text] [Related]
4. Minichromosome Maintenance Protein 7 is a potential therapeutic target in human cancer and a novel prognostic marker of non-small cell lung cancer. Toyokawa G; Masuda K; Daigo Y; Cho HS; Yoshimatsu M; Takawa M; Hayami S; Maejima K; Chino M; Field HI; Neal DE; Tsuchiya E; Ponder BA; Maehara Y; Nakamura Y; Hamamoto R Mol Cancer; 2011 May; 10():65. PubMed ID: 21619671 [TBL] [Abstract][Full Text] [Related]
5. Expression of minichromosome maintenance 7 (MCM7) in small lung adenocarcinomas (pT1): Prognostic implication. Fujioka S; Shomori K; Nishihara K; Yamaga K; Nosaka K; Araki K; Haruki T; Taniguchi Y; Nakamura H; Ito H Lung Cancer; 2009 Aug; 65(2):223-9. PubMed ID: 19144445 [TBL] [Abstract][Full Text] [Related]
6. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR. Chen C; Peng S; Li P; Ma L; Gan X Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma. Liu H; Liu B; Hou X; Pang B; Guo P; Jiang W; Ding Q; Zhang R; Xin T; Guo H; Xu S; Pang Q J Neurooncol; 2017 May; 132(3):409-417. PubMed ID: 28321704 [TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients. Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390 [TBL] [Abstract][Full Text] [Related]
9. Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. Ning Z; Wang A; Liang J; Liu J; Zhou T; Yan Q; Wang Z Int J Clin Exp Pathol; 2014; 7(5):2462-9. PubMed ID: 24966957 [TBL] [Abstract][Full Text] [Related]
10. Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2. Zhao D; Han W; Liu X; Cui D; Chen Y Thorac Cancer; 2017 Jul; 8(4):320-327. PubMed ID: 28509438 [TBL] [Abstract][Full Text] [Related]
11. High NEK2 Expression Is a Predictor of Tumor Recurrence in Hepatocellular Carcinoma Patients After Hepatectomy. Wubetu GY; Morine Y; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Ikemoto T; Saito YU; Imura S; Shimada M Anticancer Res; 2016 Feb; 36(2):757-62. PubMed ID: 26851035 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer. Zeng YR; Han ZD; Wang C; Cai C; Huang YQ; Luo HW; Liu ZZ; Zhuo YJ; Dai QS; Zhao HB; Liang YX; Zhong WD BMC Urol; 2015 Aug; 15():90. PubMed ID: 26320076 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of geminin in colorectal cancer: Implication of prognostic significance. Nishihara K; Shomori K; Tamura T; Fujioka S; Ogawa T; Ito H Oncol Rep; 2009 May; 21(5):1189-95. PubMed ID: 19360293 [TBL] [Abstract][Full Text] [Related]
14. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions. Choy B; LaLonde A; Que J; Wu T; Zhou Z Hum Pathol; 2016 Nov; 57():126-135. PubMed ID: 27476776 [TBL] [Abstract][Full Text] [Related]
15. Low expression of NEK2 is associated with hepatocellular carcinoma progression and poor prognosis. Fu L; Liu S; Wang H; Ma Y; Li L; He X; Mou X; Tong X; Hu Z; Ru G Cancer Biomark; 2017 Jul; 20(1):101-106. PubMed ID: 28759960 [TBL] [Abstract][Full Text] [Related]
16. NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. Bai R; Yuan C; Sun W; Zhang J; Luo Y; Gao Y; Li Y; Gong Y; Xie C Int J Biol Sci; 2021; 17(8):1995-2008. PubMed ID: 34131401 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer. Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis. Zhong X; Chen X; Guan X; Zhang H; Ma Y; Zhang S; Wang E; Zhang L; Han Y Histopathology; 2015 Jan; 66(2):192-200. PubMed ID: 24805087 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2. Zhao D; Han W; Liu X; Cui D; Chen Y Thorac Cancer; 2017 Jul; 8(4):304-311. PubMed ID: 28514100 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer. Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]